159 related articles for article (PubMed ID: 8209017)
1. Color Doppler ultrasonography in the differential diagnosis of focal hepatic lesions. The SH U 508 A (Levovist) experience.
Maresca G; Barbaro B; Summaria V; De Gaetano AM; Salcuni M; Mirk P; Marano P
Radiol Med; 1994 May; 87(5 Suppl 1):41-9. PubMed ID: 8209017
[TBL] [Abstract][Full Text] [Related]
2. [Hepatic focal lesions: role of color Doppler ultrasonography with contrast media].
Pennisi F; Farina R; Politi G; Lombardo R; Puleo S
Radiol Med; 1998 Dec; 96(6):579-87. PubMed ID: 10189920
[TBL] [Abstract][Full Text] [Related]
3. Color Doppler imaging of liver metastases. The value phase-III of a US contrast agent: SH U 508 A (Levovist) Schering.
Campani R; Bozzini A; Calliada F; Bottinelli O; Anguissola R; Conti MP; Corsi G
Radiol Med; 1994 May; 87(5 Suppl 1):32-40. PubMed ID: 8209016
[TBL] [Abstract][Full Text] [Related]
4. Characterization of focal hepatic lesions in cirrhotic patients by Pulse Inversion Harmonic Imaging US contrast specific technique with Levovist.
Quaia E; Forgács B; Calderan L; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2002 Oct; 104(4):285-94. PubMed ID: 12569309
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of SH U 508 A (Levovist) in color Doppler ultrasonography of hepatocellular carcinoma vascularization.
Angeli E; Carpanelli R; Crespi G; Zanello A; Sironi S; Del Maschio A
Radiol Med; 1994 May; 87(5 Suppl 1):24-31. PubMed ID: 8209014
[TBL] [Abstract][Full Text] [Related]
6. Enhanced color flows in hepatic tumors.
Yang CC; Chen CH; Yeh YH
Hepatogastroenterology; 2002; 49(48):1506-9. PubMed ID: 12397719
[TBL] [Abstract][Full Text] [Related]
7. Color doppler ultrasound of liver lesions: signal enhancement after intravenous injection of the ultrasound contrast agent Levovist.
Ernst H; Hahn EG; Balzer T; Schlief R; Heyder N
J Clin Ultrasound; 1996 Jan; 24(1):31-5. PubMed ID: 8655665
[TBL] [Abstract][Full Text] [Related]
8. Sonographic evaluation of focal nodular hyperplasias (FNH) of the liver with a transpulmonary galactose-based contrast agent (Levovist).
Uggowitzer M; Kugler C; Gröll R; Mischinger HJ; Stacher R; Fickert P; Weiglein A
Br J Radiol; 1998 Oct; 71(850):1026-32. PubMed ID: 10211062
[TBL] [Abstract][Full Text] [Related]
9. Focal hepatic lesions: evaluation with contrast-enhanced gray-scale harmonic US.
Jang HJ; Lim HK; Lee WJ; Kim SH; Kim MJ; Choi D; Lee SJ; Lim JH
Korean J Radiol; 2003; 4(2):91-100. PubMed ID: 12845304
[TBL] [Abstract][Full Text] [Related]
10. [Pulse inversion ultrasonography with ultrasonography contrast media (levovist) in the evaluation of hepatic metastasis].
Giovagnoni A; Martegani A; Aiani L; Ligabue G; Romagnoli R; Del Favero C
Radiol Med; 2001 Mar; 101(3):111-7. PubMed ID: 11402947
[TBL] [Abstract][Full Text] [Related]
11. Focal hepatic masses: enhancement patterns with SH U 508A and pulse-inversion US.
Dill-Macky MJ; Burns PN; Khalili K; Wilson SR
Radiology; 2002 Jan; 222(1):95-102. PubMed ID: 11756711
[TBL] [Abstract][Full Text] [Related]
12. [Native and signal-enhanced power Doppler sonography for characterization of liver lesions].
Strunk H; Stuckmann G; Fröhlich E; Textor J; Wilhelm K; Hortling N; Remig J
Rofo; 1998 Apr; 168(4):344-51. PubMed ID: 9589096
[TBL] [Abstract][Full Text] [Related]
13. Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings.
Fujimoto M; Moriyasu F; Nishikawa K; Nada T; Okuma M
AJR Am J Roentgenol; 1994 Nov; 163(5):1099-104. PubMed ID: 7976882
[TBL] [Abstract][Full Text] [Related]
14. Color Doppler flow imaging of renal disease. Value of a new intravenous contrast agent: SH U 508 A (Levovist).
Filippone A; Muzi M; Basilico R; Di Giandomenico V; Trapani AR; Bonomo L
Radiol Med; 1994 May; 87(5 Suppl 1):50-8. PubMed ID: 8209018
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced power Doppler sonography: improved detection of characteristic flow patterns in focal liver lesions.
Hosten N; Puls R; Lemke AJ; Steger W; Zendel W; Zwicker C; Felix R
J Clin Ultrasound; 1999; 27(3):107-15. PubMed ID: 10064407
[TBL] [Abstract][Full Text] [Related]
16. The Italian experience with SH U 508 A (Levovist) in breast disease.
Spreafico C; Lanocita R; Frigerio LF; Di Tolla G; Garbagnati F; Milella M; Marchianò A; Piragine G; Damascelli B
Radiol Med; 1994 May; 87(5 Suppl 1):59-64. PubMed ID: 8209019
[TBL] [Abstract][Full Text] [Related]
17. Feasibility study of an ultrasound contrast agent (levovist) in color Doppler imaging of liver neoplasms.
Jiang Y; Dai Q; Liu J; Zhang J; Chang X; Cai S; Tan L
Chin Med Sci J; 1999 Sep; 14(3):167-9. PubMed ID: 12903818
[TBL] [Abstract][Full Text] [Related]
18. Echo-enhanced Doppler sonography of focal nodular hyperplasia of the liver.
Uggowitzer MM; Kugler C; Mischinger HJ; Gröll R; Ruppert-Kohlmayr A; Preidler KW; Quehenberger F
J Ultrasound Med; 1999 Jul; 18(7):445-51; quiz 453-4. PubMed ID: 10400046
[TBL] [Abstract][Full Text] [Related]
19. Possibility of differentiating small hyperechoic liver tumours using contrast-enhanced colour Doppler ultrasonography: a preliminary study.
Tano S; Ueno N; Tomiyama T; Kimura K
Clin Radiol; 1997 Jan; 52(1):41-5. PubMed ID: 9022579
[TBL] [Abstract][Full Text] [Related]
20. Application of superb microvascular imaging in focal liver lesions.
He MN; Lv K; Jiang YX; Jiang TA
World J Gastroenterol; 2017 Nov; 23(43):7765-7775. PubMed ID: 29209117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
